SCHEMBL11169440

SCHEMBL11169440

CC(=O)Oc1cc2c(c(Sc3ccccc3)c1OC(C)=O)CCN(C)CC2OC(=O)/C=C/C(=O)OC1CN(C)CCc2c1cc(OC(C)=O)c(OC(C)=O)c2Sc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.32
▸ NPY1R P25929 1/20 0.32
▸ NPY2R P49146 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ DRD2 P14416 3/20 0.32
▸ DRD1 P21728 3/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ DRD5 P21918 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ PABPC1 P11940 1/20 0.30
▸ EIF4H Q15056 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11169289 0.87 CYP3A4 (0.38) KDM4ENPY1RNPY2RSMN1; SMN2DRD1
Fumaric Acid SCHEMBL11169435 0.78 SMN1; SMN2 (0.41) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
Fumaric Acid SCHEMBL11169441 0.78 SMN1; SMN2 (0.41) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
SCHEMBL10700513 0.75 CYP3A4 (0.47) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
SCHEMBL10702749 0.74 DRD1 (0.41) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
SCHEMBL11171000 0.73 DRD1 (0.38) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
SCHEMBL11171087 0.69 TDP1 (0.35) SMN1; SMN2DRD2DRD1TDP1L3MBTL1
SCHEMBL7329836 0.68 DRD1 (0.60) KDM4EDRD2DRD1CYP3A4CYP2D6
SCHEMBL11155684 0.67 DRD2 (0.41) KDM4ENPY1RNPY2RSMN1; SMN2DRD2
Hydrochloric Acid SCHEMBL7328826 0.67 DRD1 (0.59) KDM4EDRD2DRD1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback